FutureMind Congress: Psychiatry, Psychosomatic Medicine & Mental Health Innovation 2026

Theme : “Integrating Mind, Brain & Technology for Next-Generation Mental Healthcare”

London, UK | September 23 – 24, 2026

About FutureMind 2026

FutureMind 2026 is a premier global forum where science, clinical care, and innovation converge to reshape mental health. In London over two days, leaders from around the world in psychiatry, psychosomatic research, neuroscience, and digital health will come together to share new knowledge, debate paradigms, and launch scalable solutions.

This congress is not just about academic exchange — it’s about turning ideas into impact. With keynotes, symposia, workshops, case sessions, and tech showcases, we aim to close the gap between research and real-world use. FutureMind is built to be actionable, inclusive, and future-oriented — a place where attendees don’t just listen but leave ready to transform care delivery

Why Attend?

Attending FutureMind 2026 offers benefits far beyond a typical conference. Here’s what sets it apart:

Hear the latest findings on neuromodulation, psychosomatic pathways, digital diagnostics, and integrated care

Advance your knowledge:

Experience demos of cutting-edge tools — from AI-based decision support to VR therapies and wearables

See innovation live:

Build relationships with global faculty, innovators, policymakers, and collaborators

Network with purpose:

Present your research or project to international peers and compete for recognition through awards

Raise your profile:

Gain strategies to influence policy, scale care models, and integrate new tools into real systems

Drive systemic change:

Walk away with frameworks, checklists, and next steps you can deploy in your organization or research

Leave with action:

2‑Days Agenda Program

FutureMind 2026

September 23-24, 2026
London, UK

Day 1

Clinical Advances & Translational Psychiatry

08:30 AM – 09:00 AM

Registration & Welcome Coffee

09:00 AM – 09:20 AM

Opening Ceremony & Welcome Remarks

09:20 AM – 10:00 AM

Keynote 1: Frontiers in Psychiatry and Brain Health Innovation

10:00 AM – 11:15 AM

Plenary: Clinical Advances in Psychopharmacology

Long-acting injectables & depot formulations
Precision dosing & pharmacogenomics
Novel mechanisms & adjunctive strategies
Managing safety, side effects & metabolic risks
Tapering, withdrawal & long-term maintenance care

11:15 AM – 11:30 AM

Coffee Break & Networking

11:30 AM – 12:45 PM

Parallel Scientific Sessions

Track 1: Long-acting Injectables & Adherence
Track 2: Precision Dosing & Biomarker-based Care
Track 3: Adjunctive & Augmentation Strategies

12:45 PM – 13:45 PM

Networking Lunch

13:45 PM – 15:00 PM

Parallel Scientific Sessions

Track 4: Novel Mechanisms in Psychopharmacology
Track 5: Safety, Side Effects & Monitoring
Track 6: Guidelines for Tapering & Maintenance Care

15:00 PM – 15:30 PM

Coffee Break

15:30 PM – 16:30 PM

Panel Discussion: Translational Psychiatry – From Lab to Clinic

Neuroimaging & functional brain mapping
Immune system & neuroinflammation research
Genetics, epigenetics & molecular psychiatry

16:30 PM – 17:00 PM

Poster & Networking Session

17:00 PM – 17:30 PM

Closing Plenary Day 1: Personalised Psychiatry & Future Care Models

Day 2

Psychosomatic Medicine, Digital Mental Health & AI

08:30 AM – 09:00 AM

Morning Coffee & Networking

09:00 AM – 09:40 AM

Keynote 2: Digital Mental Health, AI & Next-Gen Care Models

09:40 AM – 11:00 AM

Plenary Panel: Psychosomatic & Brain–Body Integration

Stress regulation & autonomic nervous system
Gut–brain axis, microbiome & psychobiotics
Functional somatic syndromes & unexplained conditions
Inflammation & psychiatric comorbidity
Psychoneuroendocrine mechanisms
Lifestyle & integrative interventions

11:00 AM – 11:15 AM

Coffee Break

11:15 AM – 12:30 PM

Parallel Scientific Sessions

Track 7: Gut–Brain Axis & Psychobiotics
Track 8: Stress, Hormones & Psychoneuroendocrinology
Track 9: Lifestyle & Mind–Body Interventions

12:30 PM – 13:30 PM

Lunch & Networking

13:30 PM – 14:45 PM

Parallel Scientific Sessions

Track 10: Digital Phenotyping & Real-time Sensing
Track 11: AI-based Clinical Decision Support
Track 12: VR/AR Applications in Therapy & Training

14:45 PM – 15:15 PM

Coffee Break

15:15 PM – 16:15 PM

Plenary: Digital Mental Health & AI Tools

Scaling digital therapeutics globally
Data ethics, privacy & responsible AI use

16:15 PM – 16:45 PM

Special Symposium: Future Horizons in Cognitive Neuroscience

16:45 PM – 17:15 PM

Awards & Recognition Ceremony

17:15 PM – 17:30 PM

Closing Remarks & Future Outlook

Note: Exact speakers, rooms and chairpersons will be assigned in the final program.

Who Should Attend?

FutureMind is tailored to a wide, cross-disciplinary audience. It’s ideal for:

Psychiatrists, psychosomatic medicine specialists, psychologists, neurologists

Mental health nurses, social workers, and allied care providers

Health policymakers, system administrators, global health NGOs

Clinical researchers, neuroscientists, and implementation scientists

Innovation leaders in pharma, biotech, digital health, and medtech

Students, trainees, and early-career investigators who wish to grow and connect

Sessions & Tracks

FutureMind 2026 is structured into major tracks and sub-tracks, each highlighting a specific dimension of psychiatry, psychosomatic medicine, and mental health innovation. Below are the tracks and their sub-tracks with short descriptions:

Clinical Advances in Psychopharmacology

Long-acting injectables and depot formulations:

Exploring innovations in sustained-release medications that improve adherence and reduce relapse

Adjunctive and augmentation strategies:

Combination approaches to enhance outcomes in treatment-resistant disorders

Precision dosing and pharmacogenomics:

How genetic insights and biomarkers personalize treatment and minimize adverse effects

Managing safety, side effects, and metabolic risk:

Best practices in monitoring and mitigating adverse drug effects

Novel mechanisms in psychopharmacology:

New targets such as glutamatergic pathways, immune modulators, and neuropeptides in development

Tapering, withdrawal, and long-term maintenance care:

Guidelines for discontinuation and ensuring sustainable recovery

Session&Track

Neuroscience & Translational Psychiatry

Neuroimaging and functional brain mapping:

Advanced imaging techniques to uncover neural pathways in psychiatric illness.

Circuit-level and connectivity models of illness:

Understanding brain networks and their role in symptoms and treatment response.

Immune system and neuroinflammation research:

The role of inflammation and immune responses in mental disorders.

Animal models bridging laboratory to clinical insights:

Preclinical models that inform human psychiatric research.

Genetics, epigenetics, and molecular psychiatry:

Latest discoveries linking genetic and epigenetic mechanisms to mental health.

Biomarkers for diagnosis and treatment prediction:

Identifying measurable indicators for early detection and personalized care.

Psychosomatic & Brain–Body Integration

Autonomic nervous system and stress regulation:

Examining how stress responses influence physical and mental health.

Inflammation and psychiatric comorbidity:

How systemic inflammation contributes to mood and psychosomatic disorders.

Gut–brain axis, microbiome, and psychobiotics:

Emerging evidence on microbiota and its role in mood and cognition.

Psychoneuroendocrine mechanisms:

The interplay of hormones, stress, and mental health outcomes.

Functional somatic and medically unexplained syndromes:

Approaches to conditions with overlapping physical and psychiatric features.

Integrative and lifestyle-based interventions:

Holistic strategies including nutrition, exercise, and mind-body practices.

Digital Mental Health & AI Tools

Telepsychiatry and hybrid models of care:

Expanding access through remote consultations and blended approaches.

VR/AR applications in therapy and training:

Immersive technologies for therapy, rehabilitation, and clinician education.

Digital phenotyping and real-time sensing:

Use of smartphones and wearables to track mental health patterns.

Data ethics, privacy, and responsible AI use:

Protecting patient rights while leveraging digital health solutions.

AI-based clinical decision support:

Artificial intelligence tools assisting diagnosis and treatment planning.

Scaling digital therapeutics and mobile interventions:

Strategies for implementing validated digital tools globally.

Participation Benefits

All participants of FutureMind 2026 will gain benefits that go beyond attendance. The congress is designed to ensure knowledge-sharing, professional growth, and recognition. Benefits include:

Full access to keynotes, sessions, workshops, and the Innovation Forum.
Certificate of Participation (with CME/CE credits if applicable).
Eligibility for research awards and recognition.
Opportunities to present work in oral, poster, or e-poster formats.
High-value networking with peers, industry experts, and global leaders.
Exclusive exposure to publishing opportunities and professional collaborations.

Submission Guidelines

Abstracts for oral, poster, or e-poster presentations should not exceed 300 words, structured into Background, Methods, Results, and Conclusion. Include 8–10 keywords and clearly identify the presenting author. Posters should be a maximum of 1m x 1m. Submissions will be peer-reviewed on novelty, scientific quality, and clinical impact.

Key Dates:

Abstract Submission Opens: 15 November 2025

Early Submission Deadline: 15 February 2026

Final Submission Deadline: 15 May 2026

Notification of Acceptance: After 24hrs Abstract Submission

Presenter Registration Deadline: 15 July 2026

Venue

About London, UK

London, the capital of the United Kingdom, is one of the world’s most vibrant and influential cities — a true global hub for business, research, culture, and innovation. Known for its rich history blended seamlessly with modern advancements, London is home to world-leading universities, research hospitals, and medical institutions, making it an ideal destination for an international congress on neuroscience, psychiatry, psychology, and mental health innovation.

Easily accessible through five international airports, London welcomes participants from all over the world. The city offers outstanding infrastructure for global events, with state-of-the-art venues, diverse accommodation options, and a well-connected transport system — including the iconic London Underground (Tube), buses, and national rail. Delegates can conveniently travel with Oyster or contactless cards for seamless mobility.

In late September, London enjoys mild and pleasant weather, averaging 18–20 °C, creating the perfect backdrop for exploration. Visitors can immerse themselves in world-famous landmarks such as Buckingham Palace, Big Ben, Tower of London, and the River Thames, or enjoy the city’s cultural wealth through museums, galleries, theatres, and historic parks.

London is also renowned for its cultural diversity, offering a global culinary experience, multilingual services, and a welcoming environment for international delegates. This blend of tradition and innovation makes London not just a venue but an inspiring destination for networking, collaboration, and scientific exchange.

Hosting the FutureMind 2026 in London ensures delegates experience both a high-impact academic program and the unforgettable energy of one of the world’s greatest cities.

Market Analysis

The global mental health sector is undergoing unprecedented growth, driven by heightened awareness, technological innovation, and the increasing prioritization of mental well-being as a public health imperative. By 2030, the market is projected to surpass USD 400 billion, reflecting a paradigm shift toward integrated, accessible, and personalized mental health care. The industry’s expansion is propelled by major advancements across pharmaceuticals, biotechnology, and digital health ecosystems. Pharmaceutical and biotech companies are developing next-generation therapeutics, including precision psychiatry solutions and long-acting formulations that improve adherence and outcomes. Meanwhile, technology firms are transforming care delivery through AI-powered diagnostics, telepsychiatry platforms, and wearable-based mental health monitoring tools, bridging the gap between patients and providers worldwide.

Policy initiatives are also accelerating growth, as governments and international organizations embed mental health services within primary care systems, emphasizing prevention, accessibility, and equity. The academic and research communities are contributing through innovations in neuroscience, psychosomatic medicine, and translational research, driving new insights into brain–body interactions. This convergence of clinical expertise, technological innovation, and evidence-based policymaking is reshaping the global mental health landscape—creating a more collaborative, data-driven, and patient-centered model poised to define the next decade of healthcare transformation.

FutureMind 2026 positions itself as a catalyst in this market evolution by providing a collaborative platform that empowers professionals, supports innovation, and aligns academia with industry and policy. The congress aims to accelerate solutions that not only advance science but also make mental health care more accessible, equitable, and effective